» Articles » PMID: 22761636

Isorhamnetin, A Flavonol Aglycone from Ginkgo Biloba L., Induces Neuronal Differentiation of Cultured PC12 Cells: Potentiating the Effect of Nerve Growth Factor

Overview
Date 2012 Jul 5
PMID 22761636
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Flavonoids, a group of compounds mainly derived from vegetables and herbal medicines, share a chemical resemblance to estrogen, and indeed some of which have been used as estrogen substitutes. In searching for possible functions of flavonoids, the neuroprotective effect in brain could lead to novel treatment, or prevention, for neurodegenerative diseases. Here, different subclasses of flavonoids were analyzed for its inductive role in neurite outgrowth of cultured PC12 cells. Amongst the tested flavonoids, a flavonol aglycone, isorhamnetin that was isolated mainly from the leaves of Ginkgo biloba L. showed robust induction in the expression of neurofilament, a protein marker for neurite outgrowth, of cultured PC12 cells. Although isorhamnetin by itself did not show significant inductive effect on neurite outgrowth of cultured PC12 cells, the application of isorhamnetin potentiated the nerve growth factor- (NGF-)induced neurite outgrowth. In parallel, the expression of neurofilaments was markedly increased in the cotreatment of NGF and isorhamnetin in the cultures. The identification of these neurite-promoting flavonoids could be very useful in finding potential drugs, or food supplements, for treating various neurodegenerative diseases, including Alzheimer's disease and depression.

Citing Articles

Antioxidant, anti-acetylcholinesterase, and anti-amyloid-β peptide aggregations of hispolon and its analogs in vitro and improved learning and memory functions in scopolamine-induced ICR mice.

Yang C, Li C, Sie Y, Chen L, Yuan Y, Hou W Bot Stud. 2024; 65(1):38.

PMID: 39692936 PMC: 11655744. DOI: 10.1186/s40529-024-00443-x.


Exploring the possible therapeutic mechanism of Danzhixiaoyao pills in depression and MAFLD based on "Homotherapy for heteropathy": A network pharmacology and molecular docking.

Chu Y, Pang B, Yang M, Wang S, Meng Q, Gong H Heliyon. 2024; 10(15):e35309.

PMID: 39170292 PMC: 11336640. DOI: 10.1016/j.heliyon.2024.e35309.


: A Leaf of Hope in the Fight against Alzheimer's Dementia: Clinical Trial Systematic Review.

Pagotto G, Santos L, Osman N, Lamas C, Fornari Laurindo L, Pomini K Antioxidants (Basel). 2024; 13(6).

PMID: 38929090 PMC: 11201198. DOI: 10.3390/antiox13060651.


Dietary Polyphenols: Review on Chemistry/Sources, Bioavailability/Metabolism, Antioxidant Effects, and Their Role in Disease Management.

Rudrapal M, Rakshit G, Singh R, Garse S, Khan J, Chakraborty S Antioxidants (Basel). 2024; 13(4).

PMID: 38671877 PMC: 11047380. DOI: 10.3390/antiox13040429.


Exploring the mechanisms under Zuogui Pill's treatment of ischemic stroke through network pharmacology and experimental verification.

Li L, Liu Y, Zheng Y, Zhu J, Wu D, Yan X Front Pharmacol. 2023; 14:1153478.

PMID: 37426810 PMC: 10323140. DOI: 10.3389/fphar.2023.1153478.


References
1.
Nagase H, Omae N, Omori A, Nakagawasai O, Tadano T, Yokosuka A . Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities. Biochem Biophys Res Commun. 2005; 337(4):1330-6. DOI: 10.1016/j.bbrc.2005.10.001. View

2.
Lim J, Yoo M, Kwon H, Kim H, Kwon Y . Wogonin induces differentiation and neurite outgrowth of neural precursor cells. Biochem Biophys Res Commun. 2010; 402(1):42-7. DOI: 10.1016/j.bbrc.2010.09.098. View

3.
Hur J, Lee P, Moon E, Kang I, Kim S, Oh M . Neurite outgrowth induced by spicatoside A, a steroidal saponin, via the tyrosine kinase A receptor pathway. Eur J Pharmacol. 2009; 620(1-3):9-15. DOI: 10.1016/j.ejphar.2009.08.016. View

4.
Sierpina V, Wollschlaeger B, Blumenthal M . Ginkgo biloba. Am Fam Physician. 2003; 68(5):923-6. View

5.
Kruttgen A, Saxena S, Evangelopoulos M, Weis J . Neurotrophins and neurodegenerative diseases: receptors stuck in traffic?. J Neuropathol Exp Neurol. 2003; 62(4):340-50. DOI: 10.1093/jnen/62.4.340. View